Literature DB >> 6273701

Antigenic analysis of polioviruses isolated from a child with agammaglobulinemia and paralytic poliomyelitis after Sabin vaccine administration.

M Hara, Y Saito, T Komatsu, H Kodama, W Abo, S Chiba, T Nakao.   

Abstract

A 3-year-old boy with agammaglobulinemia developed paralytic poliomyelitis on day 553 after being fed poliovaccine. Non-vaccine-like type 2 polioviruses were isolated from 22 stools obtained within 684 days after the onset of illness. Antigenic variations were observed among these viruses. The non-vaccine-like virus isolated 1 week after the onset of paralysis differed in virulence from the Sabin type 2 vaccine strain in the neurovirulence test in monkeys, and did not have the same antigenic character as the wild virulent strains. Another virus isolated on day 348 before the onset of illness was also classified as non-vaccine-like. However, the Sabin type 2 strain was shown to be homologous with this strain by the McBride test. Some Sabin-like particles were found in this stock virus. We may conclude that the non-vaccine-like virus isolates were derived from Sabin vaccine by antigenic variation that occurred during long-term multiplication in the intestinal tract.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6273701     DOI: 10.1111/j.1348-0421.1981.tb00095.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  13 in total

Review 1.  Role of antibodies in controlling viral disease: lessons from experiments of nature and gene knockouts.

Authors:  P P Sanna; D R Burton
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion.

Authors:  J Martín; G Dunn; R Hull; V Patel; P D Minor
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Long-term excretion of vaccine-derived poliovirus by a healthy child.

Authors:  Javier Martín; Kofi Odoom; Gráinne Tuite; Glynis Dunn; Nicola Hopewell; Gill Cooper; Catherine Fitzharris; Karina Butler; William W Hall; Philip D Minor
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

4.  Prolonged faecal excretion of poliovirus in a nurse with common variable hypogammaglobulinaemia.

Authors:  S A Misbah; P A Lawrence; J B Kurtz; H M Chapel
Journal:  Postgrad Med J       Date:  1991-03       Impact factor: 2.401

5.  Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication.

Authors:  Andrew J Macadam; Geraldine Ferguson; David M Stone; Janet Meredith; Sarah Knowlson; Ghazi Auda; Jeffrey W Almond; Philip D Minor
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

6.  Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient.

Authors:  Chen-Fu Yang; Hour-Young Chen; Jaume Jorba; Hui-Chih Sun; Su-Ju Yang; Hsiang-Chi Lee; Yhu-Chering Huang; Tzou-Yien Lin; Pei-Jer Chen; Hiroyuki Shimizu; Yorihiro Nishimura; Andi Utama; Mark Pallansch; Tatsuo Miyamura; Olen Kew; Jyh-Yuan Yang
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

7.  Community-acquired poliovirus infection in children with primary immunodeficiencies in Tunisia.

Authors:  Hinda Triki; Mohamed Ridha Barbouche; Olfa Bahri; Mohamed Bejaoui; Koussay Dellagi
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

8.  Characterization of Poliovirus Neutralization Escape Mutants of Single-Domain Antibody Fragments (VHHs).

Authors:  Lise Schotte; Bert Thys; Mike Strauss; David J Filman; Bart Rombaut; James M Hogle
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

9.  Alteration in oligonucleotide fingerprint patterns of the viral genome in poliovirus type 2 isolated from paralytic patients.

Authors:  T Yoneyama; A Hagiwara; M Hara; H Shimojo
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

10.  Estimating the risk of re-emergence after stopping polio vaccination.

Authors:  Akira Sasaki; Yoshihiro Haraguchi; Hiromu Yoshida
Journal:  Front Microbiol       Date:  2012-05-21       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.